102 related articles for article (PubMed ID: 3244744)
1. Hemodynamic and electrocardiographic actions of the new intracellular calcium antagonist, KT-362, in the conscious dog.
Hartman JC; Al-Wathiqui MH; Brooks HL; Gross GJ; Warltier DC
Pharmacology; 1988; 37(6):376-84. PubMed ID: 3244744
[TBL] [Abstract][Full Text] [Related]
2. Collateral blood flow following acute coronary artery occlusion: comparison of a new intracellular calcium antagonist (KT-362) and diltiazem.
Farber NE; Gross GJ
J Cardiovasc Pharmacol; 1989 Jul; 14(1):66-72. PubMed ID: 2475718
[TBL] [Abstract][Full Text] [Related]
3. Effects of KT-362, a new calcium release blocker, on vascular selectivity and hemodynamic actions in anesthetized dogs.
Wakabayashi S; Mochizuki S; Tomiyama A; Shibata S
Jpn J Pharmacol; 1990 Sep; 54(1):23-32. PubMed ID: 2273645
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of verapamil enantiomer combinations in conscious dogs.
Pagel PS; Hettrick DA; Lowe D; Gowrie PW; Kersten JR; Bosnjak ZJ; Warltier DC
Eur J Pharmacol; 1998 May; 348(2-3):213-21. PubMed ID: 9652336
[TBL] [Abstract][Full Text] [Related]
5. Comparative cardiac effects of KT-362 and verapamil in isolated heart--correlation to calcium channel current depression.
Buljubasic N; Marijic J; Stowe DF; Gross GJ; Kampine JP; Bosnjak ZJ
J Cardiovasc Pharmacol; 1991 Oct; 18(4):594-604. PubMed ID: 1724538
[TBL] [Abstract][Full Text] [Related]
6. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
[TBL] [Abstract][Full Text] [Related]
7. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
8. Negative chronotropic actions of sufentanil and vecuronium in chronically instrumented dogs pretreated with propranolol and/or diltiazem.
Schmeling WT; Kampine JP; Warltier DC
Anesth Analg; 1989 Jul; 69(1):4-14. PubMed ID: 2568103
[TBL] [Abstract][Full Text] [Related]
9. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G
J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
[TBL] [Abstract][Full Text] [Related]
11. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of a new vascular intracellular calcium antagonist, KT-362, in the stunned myocardium.
Farber NE; Gross GJ
J Pharmacol Exp Ther; 1989 Jan; 248(1):39-43. PubMed ID: 2536431
[TBL] [Abstract][Full Text] [Related]
13. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
Kantelip JP; Alatienne M; Talmant JM; Ghyselinck N; Duchêne-Marullaz P
Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of and interaction between calcium blocking drugs and anesthetics in chronically instrumented dogs. I. Verapamil and halothane.
Chelly JE; Rogers K; Hysing ES; Taylor A; Hartley C; Merin RG
Anesthesiology; 1986 May; 64(5):560-7. PubMed ID: 3963476
[TBL] [Abstract][Full Text] [Related]
15. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure.
Su J; Renaud N; Carayon A; Crozatier B; Hittinger L
Br J Pharmacol; 1994 Oct; 113(2):395-402. PubMed ID: 7834190
[TBL] [Abstract][Full Text] [Related]
16. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
17. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
Kates RA; Zaggy AP; Norfleet EA; Heath KR
Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
[TBL] [Abstract][Full Text] [Related]
18. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog.
Nichols AJ; Koster PF; Ohlstein EH
Br J Pharmacol; 1990 Mar; 99(3):597-601. PubMed ID: 2184913
[TBL] [Abstract][Full Text] [Related]
19. Cardiac and systemic hemodynamic actions of the slow channel calcium blocking agent, KB-944.
Pelc LR; Gross GJ; Warltier DC
Gen Pharmacol; 1985; 16(6):585-90. PubMed ID: 4085780
[TBL] [Abstract][Full Text] [Related]
20. Plasma diltiazem levels, cardiovascular function, and coronary hemodynamics during enflurane anesthesia in the dog.
Kapur PA; Campos JH; Buchea OC
Anesth Analg; 1986 Sep; 65(9):918-24. PubMed ID: 3740491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
